Interestingly, gefitinib (an EGFR inhibitor) treatment was correlated with low CIC protein expression in a non-small cell lung cancer model11, which may be due inhibition of CIC mRNA production as shown here. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.